GEN Exclusives

More »
New Products

Related to Look, No Label! Label-Free MST

    • Purification Column for Histidine-Tagged Proteins
    • Roche
    • The cOmplete His-Tag Purification Column for researchers performing histidine-tagged protein purification from lysates uses nickel-chelate chemistry and is compatible with reducing agents such as dithiothreitol, metalloproteinase-inhibiting reagent
    • Calcium Indicator Kit
    • Molecular Devices
    • The Fura-2 QBT Calcium kit combines the calcium indicator Fura-2 with masking technology to provide a ratiometric fluorescence-based assay for detecting and quantitating changes in intracellular calcium. The kit is designed to reduce background flu
    • ELISA Kits
    • Abcam
    • SimpleStep kits are single-wash, colorimetric sandwich ELISAs that are designed to retain the familiar ELISA process and data outputs. Designed for users who may lack specialized training or instrumentation, SimpleStep kits can be used with fewer s
    • Protein Analysis System
    • ForteBIO
    • The Octet HTX instrument can monitor up to 96 biosensors simultaneously, enabling label-free detection for protein quantitation and kinetic characterization, and it can read 8, 16, 32, 48, or 96 wells in parallel. If whole-plate detection is carrie
    • Stain-Free Gel Visualization Application
    • Syngene
    • The lighting and filter conditions in the G:BOX XR5 image analysis system can be adjusted to allow the visualization of proteins on stain-free gels. This G:BOX XR5 application was evaluated in tests conducted with a Criterion TGX stain-free gel tha
  • Page 1 of 1 (6 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?